Moses 2.0与非Moses技术在钬激光前列腺剜除术中的随机对照试验
该双盲随机对照试验在27例接受HoLEP的患者中比较Moses 2.0与非Moses技术的剜除效率,采用同体左右叶随机对照设计。结果示专家操作时Moses 2.0剜除时间更短、效率更高,光纤损耗更小;主观评价多项指标优于非Moses。
要点
- 专家操作时Moses 2.0剜除效率更高(1.75 vs 1.05 g/min,P=0.05)
- Moses 2.0光纤损耗更小(3.5 vs 16.8 mm,P<0.01)
- 主观评价中Moses 2.0在切割锐度、止血等多方面更优
核心结论
- 专家使用Moses 2.0时剜除效率高于非Moses技术,主观评价亦支持Moses 2.0。
研究设计与样本
- 双盲随机对照试验,在Mayo Clinic Arizona纳入27例接受HoLEP的患者,使用Lumenis Pulse™ 120H激光系统。
- 患者随机分配为右叶用Moses 2.0、左叶用非Moses,或相反。
主要发现
- 全队列中Moses 2.0光纤损耗小于非Moses(3.5 vs 16.8 mm,P<0.01)。
- 专家操作时Moses 2.0剜除时间更短(21 vs 36.7 min,P=0.016),剜除效率更高(1.75 vs 1.05 g/min,P=0.05)。
- 学员操作时Moses 2.0止血激光时间更短(4.1 vs 9 min,P=0.035)。
- 主观评价中Moses 2.0在切口锐度、光纤控制、组织分离、组织损伤、止血、可见度及碳化方面评分高于标准技术,观察者间相关系数为0.63。
关键数值与推荐
- 主要结局为单叶剜除效率;次要结局包括单叶激光时间、激光能量、剜除与止血激光能量及光纤回烧。
临床怎么用
- 在专家手中,Moses 2.0可提升HoLEP剜除效率并减少光纤损耗;学员使用时止血时间更短。
局限性
- 样本量较小(27例),结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the enucleation efficiency of Moses 2.0 with non-Moses technology in patients undergoing holmium laser enucleation of the prostate (HoLEP). PATIENTS AND METHODS: A double-blinded, randomised study of patients undergoing HoLEP at the Mayo Clinic in Arizona, using the Lumenis Pulse™ 120H laser system. Patients were randomised to either right lobe enucleation using Moses 2.0 and left lobe enucleation using non-Moses, or the opposite. The primary outcome was individual lobe enucleation efficiency. Secondary outcomes included individual lobe laser time, laser energy, individual enucleation and haemostasis laser energies, and fibre burn back. Two independent reviewers watched videos of the procedures and provided a subjective evaluation of the technologies. RESULTS: A total of 27 patients were included in the study. For the entire cohort, Moses 2.0 had less fibre degradation (3.5 vs 16.8 mm, P < 0.01) compared to non-Moses. When HoLEP procedures were performed by an expert, Moses 2.0 resulted in shorter enucleation time (21 vs 36.7 min, P = 0.016) and higher enucleation efficiency (1.75 vs 1.05 g/min, P = 0.05) compared to non-Moses. When HoLEP was performed by trainees, the Moses 2.0 cohort had a shorter haemostasis laser time (4.1 vs 9 min, P = 0.035) compared to the non-Moses. Fibre degradation was lower with Moses 2.0 compared to non-Moses for both experts and trainees. Moses 2.0 received a higher score than the standard technology for the incision sharpness, fibre control, tissue separation, tissue damage, haemostasis, visibility, and charring. The overall inter-observer correlation coefficient was 0.63. CONCLUSION: Moses 2.0 has higher enucleation efficiency compared to non-Moses when used by experts. The subjective evaluation favoured Moses 2.0.
引用
- Nevo A, Faraj KS, Cheney SM, et al. Holmium laser enucleation of the prostate using Moses 2.0 vs non-Moses: a randomised controlled trial. BJU Int. 2020. PMID: 33025749. doi:10.1111/bju.15265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。